One genomic test, Oncotype Dx, is a useful tool that can help predict the likelihood of benefit from chemotherapy, as well as the risk of recurrence for invasive breast cancer. health.harvard.edu/blog/can-some-postmenopausal-women-with-breast-cancer-skip-chemotherapy-2021041522344
from Tumblr https://getsbeauty.tumblr.com/post/649414830368882688
No comments:
Post a Comment